Short answer: there is no blood-test panel that makes non-prescribed anabolic-androgenic steroid (AAS) or PED use safe. Useful cardiovascular monitoring commonly includes a full blood count, lipid panel, kidney function, electrolytes, glucose assessment and blood pressure, with ApoB, lipoprotein(a), urine albumin and other tests added when the clinical question supports them.
Testing has value only when the result is interpreted correctly and changes what happens next. A normal panel cannot exclude high blood pressure, arrhythmia, coronary plaque or unfavourable heart remodelling. An abnormal panel should not be managed by adding supplements while continuing the suspected cause unchanged.
Key takeaway: bring a clinician the full exposure history, not just a list of desired tests. The right panel, timing and follow-up depend on your baseline risk, symptoms, drugs, previous results and current health.
Table of contents
- What blood tests can and cannot do
- Core cardiovascular monitoring discussion
- Full blood count and haematocrit
- Lipids, ApoB and lipoprotein(a)
- Kidney function, electrolytes and urine albumin
- Glucose and HbA1c
- Liver tests and training confounders
- Hormonal tests and PSA
- Specialised cardiovascular markers
- Blood pressure is essential but not a blood test
- When should testing occur?
- How to prepare for comparable results
- How to interpret results responsibly
- When blood work is not enough
- Frequently asked questions
- References
What blood tests can and cannot do
Blood work can identify important risk markers and organ stress. It can show an adverse lipid pattern, erythrocytosis, kidney dysfunction, diabetes-related risk, electrolyte disturbance and some liver or hormonal abnormalities.
It cannot directly show:
- whether coronary plaque is present;
- whether the left ventricle is enlarged or functioning normally;
- an intermittent arrhythmia that did not occur during testing;
- masked hypertension or the overnight blood-pressure pattern;
- whether an underground product contains what its label claims; or
- that future AAS or PED use will be safe.
The complete heart-health guide for enhanced athletes explains how symptoms, examination, blood pressure, ECG, imaging and blood tests fit together.
Core cardiovascular monitoring discussion
| Test or measurement | Why it may matter | Important limitation |
|---|---|---|
| Full blood count | Haemoglobin, haematocrit and cell counts | Hydration, altitude, smoking and sleep apnoea affect interpretation |
| Lipid panel | LDL-C, HDL-C, triglycerides and non-HDL-C | Does not directly count atherogenic particles |
| ApoB | Approximates the number of atherogenic particles | Not required for every person or every repeat test |
| Lipoprotein(a) | Identifies a largely inherited risk factor | Usually stable; not an "on-cycle" response marker |
| Kidney function and electrolytes | eGFR, creatinine, sodium and potassium context | Muscle mass, creatine and hydration can affect creatinine |
| Urine albumin-to-creatinine ratio | Can identify albumin leakage and kidney risk | Hard exercise, illness and sample conditions can confound results |
| Glucose and HbA1c | Diabetes and metabolic-risk assessment | Haematological conditions can affect HbA1c interpretation |
| Liver panel | Liver and biliary context | AST and ALT can rise after muscle-damaging training |
| Blood pressure | Major modifiable cardiovascular risk factor | Requires validated equipment and repeated correct measurements |
This is a discussion framework, not a universal pathology request. A GP may add or remove tests based on age, sex, prescribed treatment, symptoms, family history and previous findings.
Full blood count and haematocrit
Androgens can stimulate red-blood-cell production. A full blood count reports haemoglobin, haematocrit, red-cell indices, white cells and platelets. Haematocrit is the proportion of blood volume occupied by red cells.
A high haematocrit can increase blood viscosity, but the risk and response cannot be decided from a blog threshold alone. Consider:
- hydration and recent fluid loss;
- altitude exposure;
- smoking or vaping;
- obstructive sleep apnoea;
- prescribed testosterone or non-prescribed AAS;
- lung or heart disease; and
- primary blood disorders.
Do not treat an elevated result with unplanned blood donation or repeated phlebotomy. That can cause iron deficiency and may leave the underlying exposure, sleep apnoea or other cause unaddressed. A clinician should decide whether the result needs confirmation, investigation, treatment change or specialist input.
Lipids, ApoB and lipoprotein(a)
AAS can lower HDL-C and increase LDL-C, non-HDL-C and ApoB. The steroids and cholesterol guide covers the mechanisms and limitations. For foundational interpretation, read cholesterol explained for athletes.
A standard panel is an appropriate starting point. ApoB may add information when LDL-C and triglycerides are discordant or metabolic risk is present. Lp(a) is largely inherited and usually needs to be measured only once in adulthood unless a clinician has a reason to repeat it.
Do not focus only on raising HDL. A supplement-induced change in HDL-C has not automatically been shown to reduce cardiovascular events. Particle burden, blood pressure, smoking, diabetes, kidney health and family history all matter.
Kidney function, electrolytes and urine albumin
Kidneys regulate fluid, electrolytes and blood pressure. Common blood markers include creatinine, estimated glomerular filtration rate (eGFR), urea, sodium and potassium. A urine albumin-to-creatinine ratio can identify albumin leakage that may not be obvious from serum creatinine alone.
Creatinine is influenced by muscle mass, meat intake, creatine supplementation, hydration and recent hard training. A muscular athlete can have a higher creatinine result without the same filtration impairment seen in a smaller person. That does not mean every elevation is harmless. A clinician may consider cystatin C, repeat testing or urine assessment when the result is uncertain.
Potassium and sodium become especially important when an athlete uses diuretics, blood-pressure medicine, insulin or other products that alter fluid and electrolyte balance. Never correct an electrolyte result with an online protocol without medical advice.
Glucose and HbA1c
Diabetes and insulin resistance increase cardiovascular risk. Fasting glucose, HbA1c and, in selected cases, an oral glucose tolerance test can assess different parts of glycaemic health.
Growth hormone exposure, rapid weight gain, sleep apnoea, diet and genetic susceptibility may worsen insulin sensitivity. A normal fasting glucose does not answer every metabolic question, while HbA1c can be affected by altered red-cell turnover or some blood conditions.
Liver tests and training confounders
ALT, AST, GGT, alkaline phosphatase and bilirubin are commonly grouped as liver tests. They do not all mean the same thing. AST and ALT can rise after strenuous, muscle-damaging exercise because skeletal muscle contains these enzymes. GGT and bilirubin add context, as do symptoms, alcohol, medicines and oral AAS exposure.
Do not automatically dismiss an abnormality as training, and do not assume it proves liver damage without assessment. If repeat testing is planned, the clinician may ask you to avoid hard training for a defined period so the result is easier to interpret. The liver enzymes for athletes guide covers this issue in depth.
Hormonal tests and PSA
Hormonal testing depends heavily on the clinical question. Total testosterone, SHBG, calculated free testosterone, LH, FSH, oestradiol, prolactin and thyroid tests may be appropriate in selected situations. During non-prescribed AAS use, some expected suppression is not a reassuring health marker, and numbers from assays can be difficult to interpret at supraphysiological concentrations.
PSA may be considered according to age, symptoms, family history and the prescriber's monitoring plan during testosterone therapy. It is not a perfect cancer test and should not be ordered or interpreted without context.
Prescribed testosterone replacement is different from supraphysiological multi-compound use. Follow the prescriber's monitoring plan rather than a generic bodybuilding checklist.
Specialised cardiovascular markers
High-sensitivity C-reactive protein
hs-CRP can contribute to cardiovascular risk assessment in selected people, but infection, injury and hard training can raise it. It is not a direct measure of coronary plaque and should not be used as a standalone score.
Homocysteine
Homocysteine can be elevated with vitamin deficiencies, kidney dysfunction, genetic variation and other factors. Lowering the number with B vitamins has not consistently translated into fewer cardiovascular events for the general population. Test only when the result will answer a defined clinical question.
Troponin
Troponin is used to assess possible heart-muscle injury, including suspected heart attack. It is not a routine wellness screen to order after every cycle. Hard endurance exercise can also cause transient elevations, making clinical context essential. Chest pain or other concerning symptoms require urgent assessment, not a self-ordered test days later.
Blood pressure is essential but not a blood test
High blood pressure often causes no symptoms and can be missed by a perfect pathology panel. Use a validated upper-arm device, correct cuff size and repeated measurements. The home blood-pressure guide gives a seven-day method, and blood pressure explained for athletes covers Australian context.
Anyone using AAS should also read steroids and blood pressure. Cardio and a low resting heart rate do not rule out hypertension.
When should testing occur?
There is no universal schedule that makes non-medical AAS use safe. A useful clinical framework may include:
- baseline assessment before a new exposure, so existing abnormalities are not mislabelled as drug effects;
- follow-up during a clinically meaningful change, with timing set around the expected effect and individual risk;
- prompt testing or assessment when symptoms or major abnormalities appear; and
- follow-up after stopping or changing exposure to check recovery rather than assuming it.
Testing once a year may be inadequate for a high-risk or changing situation and excessive self-testing can also create noise. A clinician should set the interval.
How to prepare for comparable results
- Follow fasting instructions exactly when they are given.
- Keep medication timing consistent unless instructed otherwise.
- Tell the clinician about creatine, protein intake, alcohol, medicines, supplements and all PEDs.
- Ask whether hard training should be avoided before liver, kidney, CK or inflammatory tests.
- Avoid testing during acute illness unless assessment cannot wait.
- Use the same laboratory where practical for serial comparisons.
- Record the date, training context and exposure rather than relying on memory.
Never change a drug, medicine, fluid intake or diet simply to produce a better test. The goal is an honest assessment, not a temporary pass.
How to interpret results responsibly
A laboratory reference interval is not the same thing as an individual treatment target. Reference intervals describe a population distribution and can vary between laboratories. Cardiovascular targets depend on total risk and clinical guidelines.
Look for:
- the direction and size of change from a comparable baseline;
- whether several related markers support the same conclusion;
- training, hydration, illness or laboratory factors that may confound it;
- symptoms or examination findings that change urgency; and
- whether the result should change exposure, treatment or investigation.
Do not interpret results by crowdsourcing isolated screenshots. The person answering may not know the units, assay, reference range, symptoms, medicines or exposure.
When blood work is not enough
Depending on symptoms, family history, examination, duration of exposure and test results, a clinician may consider:
- a 12-lead ECG;
- echocardiography;
- ambulatory rhythm monitoring;
- 24-hour ambulatory blood-pressure monitoring;
- sleep-apnoea testing; or
- specialist cardiovascular assessment.
Chest pain, fainting, severe breathlessness, new neurological symptoms or a rapidly worsening condition require urgent care. Call Triple Zero (000) for a possible medical emergency.
Frequently asked questions
What is the most important blood test during steroid use?
There is no single most important test. Full blood count, lipids, kidney, glucose and other tests answer different questions, while blood pressure and symptoms are not captured by blood work.
How often should enhanced athletes get blood tests?
Frequency depends on baseline risk, exposure, symptoms and previous results. There is no universal schedule that makes non-prescribed AAS use safe.
Should enhanced athletes test ApoB?
ApoB can add particle-number information, particularly when LDL-C and other markers are discordant. A clinician can decide when it is useful.
What haematocrit level is dangerous?
Risk cannot be assigned from a generic internet threshold alone. Confirm the result and assess hydration, sleep apnoea, smoking, altitude, androgen exposure and symptoms with a clinician.
Can hard training raise ALT and AST?
Yes. Muscle-damaging exercise can raise both enzymes, but an abnormal result should not automatically be dismissed. GGT, bilirubin, CK, symptoms and repeat testing may add context.
Does high creatinine mean kidney damage in a bodybuilder?
Not necessarily. Muscle mass, creatine, meat intake and hydration affect creatinine. Kidney disease is still possible, so interpret it with eGFR, urine testing, trends and clinical context.
Can a normal panel prove steroids are safe?
No. Blood tests do not exclude high blood pressure, arrhythmia, coronary plaque or abnormal heart structure and function.
Can supplements replace blood testing?
No. Supplements cannot diagnose risk or make AAS exposure safe. They may also interact with medicines and alter laboratory results.
Can an Australian GP order these tests?
A GP can assess your history and order tests that are clinically appropriate. Be honest about prescribed and non-prescribed exposures so the request and interpretation are useful.
References and further reading
- National Heart Foundation of Australia: Blood tests for heart disease
- National Heart Foundation of Australia: Manage high blood cholesterol
- National Heart Foundation of Australia: Blood pressure and your heart
- Cardiovascular Disease in Anabolic Androgenic Steroid Users
- Illicit Anabolic Steroid Use and Cardiovascular Status in Men and Women
- Cardiovascular Toxicity of Illicit Anabolic-Androgenic Steroid Use
This article provides general harm-reduction education, not an individual pathology request or treatment plan. Non-prescribed AAS and PED use carries health risks. Work with a qualified health professional.